1Hrabar D. Therapy of malignant liver tumors. Acta Med Croatica,2003,57 ( 3 ) :241-248. 被引量：1
2Bodei L, Kassis AI, Adelstein S J, et al. Radionuclide therapy with iodine- 125 and other auger- electron- emitting radionuclides: experimental models and clinical applications. Cancer Biother Radiopharm, 2003, 18(6) :861-877. 被引量：1
3Jeong JM, Chung JK. Therapy with ^188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials.Cancer Biother Radiopharm, 2003, 18(5) :707-717. 被引量：1
4Lambert B, Bacher K, Defreyne L, et al. ^188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med,2005, 46(1) :60-66. 被引量：1
5Verel I, Visser GW, Boellaard R, et al. Quantitative ^89Zr immunoPET for in vivo scouting of ^90Y- labeled monoclonal antibodies in xenograft- bearing nude mice. J Nucl Med, 2003,44 (10): 1663-1670. 被引量：1
6Mohr L, Yeung A, Aloman C, et al. Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology, 2004, 127 ( 5Suppl 1 ) :S225-231. 被引量：1
7Bushnell D, Menda Y, Madsen M, et al. Assessment of hepatic toxicity from treatment with ^90Y-SMT 487 ( OctreoTher( TM ) ) in patients with diffuse somatostatin receptor positive liver metastases.Cancer Biother Radiopharm, 2003, 18(4) :581-588. 被引量：1
8Borchers H, Kirschner Hermanns R, Brehmer B, et al . Permanent 125 I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. BJU Int,2004, 94(6) :805-811. 被引量：1
9Martinez Monge R, Garran C, Vivas I, et al . Percutaneous CTguided ^103Pd implantation for the medically inoperable patient with T1N0M0 non-small cell lung cancer: a case report. Brachytherapy,2004, 3(3) :179-181. 被引量：1
10Liu MD, Uaje MB, AlGhazi MS, et al. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg, 2004, 70( 11 ) :947-953. 被引量：1
10Zeng ZC, Tang ZY, Fan J, et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma[ J]. Cancer J,2004,10(5 ) :307-316. 被引量：1
